Barriers to diagnosing and managing heart failure in primary care

Medical Journal of Australia

Volumn 181, Issue 2, 2004, Pages 78-81

  Phillips, Susan M ^a   Marton, Richard L ^b   Tofler, Geoffrey H ^a  

^a National Institute of Clinical Studies   (Australia)

^b RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; COMMUNITY CARE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG CONTRAINDICATION; ECHOCARDIOGRAPHY; EVIDENCE BASED MEDICINE; FEMALE; GENERAL PRACTITIONER; HEART FAILURE; HUMAN; INTERVIEW; MALE; MEDICAL SPECIALIST; PHYSICIAN ATTITUDE; PRIMARY MEDICAL CARE; QUALITATIVE ANALYSIS; RURAL AREA; SIDE EFFECT; SYMPTOMATOLOGY; TELEPHONE; URBAN AREA;

EID: 4043178595     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb06178.x     Document Type: Article

References (21)

1. Krum H, Tonkin AM, Currie R, et al. Chronic heart failure in Australian general practice: the Cardiac Awareness Survey and Evaluation (Case) Study. Med J Aust 2001; 174: 439-444.
2. Davis RC, Hobbs FDR, Lip GYH. ABC of heart failure. History and epidemiology. BMJ 2000; 320; 39-42.
3. Senes S, Britt H. A general practice view of cardiovascular disease and diabetes in Australia. Australian Institute of Health and Welfare Cardiovascular Disease Series No. 18. Canberra: AIHW, 2001. (AIHW catalogue no. CVD 17.) Available at: www.aihw.gov.au (accessed May 2003).
4. Coombes ID, Sanders DCJ, Thiele JM, et al. The extended role of the clinical pharmacist in the management of heart failure and acute coronary syndromes. J Pharm Pract Res 2002; 32: 17-23.
5. Bart BA, Gattis WA, Diem SJ, O'Connor CM. Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. Am J Cardiol 1997; 79: 1118-1120.
6. Stafford RS, Saglam D, Blumenthal D. National patterns of angiotensin converting enzyme inhibitor use in congestive heart failure. Arch Intern Med 1997; 157: 2460-2464.
7. National Institute of Clinical Studies. Evidence-practice gaps report. Vol. 1. Melbourne: NICS, 2003. Available at: www.nicsl.com.au (accessed Mar 2004.
8. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and chronic heart failure. The SOLVD investigators. N Engl J Med 1991; 325: 293-302.
9. Doughty RN, Rodgers A, Sharpe N, MacMahon S. Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomised controlled trials. Eur Heart J 1997; 18: 560-565.
10. Glover J, Harris K, Tennant S, editors. A social health atlas of Australia. 2nd ed. Vol. 1. Adelaide: Adelaide University and Openbook Publishers, 1999. Available at: www.publichealth.gov.au (accessed May 2003).
11. National Health and Medical Research Council. National statement on ethical conduct in research involving humans. Canberra: NHMRC, 1999. Available at: www.nhmrc.gov.au (accessed May 2004).
12. Glesne C, Peshkin A. Becoming qualitative researchers: an introduction. New York: Long-man Publishing Group, 1992.
13. Denzin NK. The research act: a theoretical introduction to sociological methods. Englewood Cliffs, NJ: Prentice-Hall, 1995.
14. Krum H; National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Chronic Heart Failure Clinical Practice Guidelines Writing Panel. Guidelines for management of patients with chronic heart failure in Australia. Med J Aust 2001; 174: 459-466.
15. Horne R, Coombes I, Davies G, et al. Barriers to optimum management of heart failure by general practitioners. Br J Gen Pract 1999; 49: 353-357.
16. Khunti K, Hearnshaw H, Baker R, Grimshaw G. Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Fail 2002; 4: 771-777.
17. Fuat A, Hungin APS, Murphy JJ. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 2003; 326: 196-200.
18. Grol R, Wensing M. What drives change? Barriers to and incentives for achieving evidence-based practice. Med J Aust 2004; 180 (6 Suppl): S57-S60.
19. Burgers JS, Grol RPTM, Zaat JOM, et al. Characteristics of effective clinical guidelines for general practice. Br J Gen Pract 2003; 53: 15-19.
20. Grol R, Dalhuijsen J, Thomas S, et al. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ 1998; 317: 858-861.
21. Massie BM, Ansari MN. Specialty care for heart failure: does it improve outcomes? Am Heart J 2003; 145: 209-213.